Navigation Links
Full Agenda Announced for CMAC 2011 - CBI'S 2nd Annual Commercialization and Market Access Congress
Date:10/18/2011

WOBURN, Mass., Oct. 18, 2011 /PRNewswire/ -- CBI is pleased to announce the full agenda for CMAC 2011 - CBI's 2nd Annual Commercialization and Market Access Congress, being held December 6-7, 2011 in Philadelphia, PA. The program, sponsored by Campbell Alliance and McKesson Specialty Care Solutions, delivers pre- and post-launch strategies, dynamic programming and extensive coverage of market access trends.

Anchored by conference chairman, Robert Besthof, Vice President, Commercial Lead, ERP U.S. & Puerto Rico, Pfizer Inc., CMAC 2011 boasts an impressive speaker lineup from AstraZeneca, Baxter, Bristol-Myers Squibb, Daiichi Sankyo, Endo, Eli Lilly, ImClone, InterMune, Metamark Genetics, Grifols, ISTA Pharmaceuticals, Shire, Vertex and many more. Attendees have the opportunity to customize their congress by choosing between workshops, pre- and post-launch tracks and participating in interactive panel discussions. Session highlights include:

  • Product Commercialization Simulation from Candidate Selection through Launch
  • Reimbursement Strategies to Ensure Favorable Coverage, Coding and Payment Decisions
  • The Emergence of Personalized Medicine
  • Global Rollout
  • Brand Commercialization in a Crowded Therapeutic Marketplace
  • Building Specialty Launch Teams
  • Re-Positioning Products Post-Launch
  • KOL Engagement to Optimize Commercialization Efforts

CMAC 2011 is the industry's only opportunity to participate in an executive-level exchange addressing the overarching product development and launch environment, as well as tactical approaches for pricing, reimbursement, product launch, commercial strategy, branding, managed care and HEOR. For more information on the conference or to view the entire agenda, please visit http://www.cbinet.com/cmac2011.  

About CBI:

CBI, a subsidiary of Advanstar, is the leading provider of market-driven, unbiased conferences for the pharmaceutical, biotechnology, medical device and healthcare industries. CBI offers specialized information presented in interactive formats by thought leaders and regulators. For more information, please visit http://www.cbinet.com.

For additional information or media inquiries, please contact: Emily Forest, Marketing Manager, at 339-298-2156.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE CBI
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma
2. TechConnect World Publishes Conference Agenda Featuring More than 2,700 Presentations Addressing Nano, Bio and Clean Technologies
3. American Society of Anesthesiologists Primary Agenda Displayed Says Dr. Barry Friedberg of Cosmetic Surgery Anesthesia
4. CBI Announces the Agenda for Their West Coast Forum on Clinical Supply Chain Management
5. CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress
6. 'Biopolymers Symposium 2010' Agenda Announced
7. Full Agenda Announced for CBIs Commercialization and Market Access Congress (CMAC 2010)
8. 2008 National Ergonomics Conference Schedule Announced, Features Four New Tracks of Programming and Focus on Corporate Sustainability and Productivity; Most Product Debuts in Expos 14-Year History
9. 2008 R&D Innovator of the Year & Scientist of the Year Finalists Announced
10. First Annual Arizona Biotech Day Announced for October 23rd 2008
11. Presenters Announced For MichBio Expos Emerging Business Showcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... announced the launch of the Supplyframe Design Lab . Located in Pasadena, ... explore the future of how hardware projects are designed, built and brought to ...
Breaking Biology Technology:
(Date:6/22/2016)... June 22, 2016  The American College of Medical Genetics ... Executive Magazine as one of the fastest-growing trade shows ... at the Bellagio in Las Vegas . ... percentage of growth in each of the following categories: net ... and number of attendees. The 2015 ACMG Annual Meeting was ...
(Date:6/22/2016)... WASHINGTON , June 22, 2016 On ... highly-anticipated call to industry to share solutions for the ... by U.S. Customs and Border Protection (CBP), explains that ... nationals are departing the United States ... criminals, and to defeat imposters. Logo - ...
(Date:6/20/2016)... 20, 2016 Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring announced ... it has secured the final acceptance by all ... Managed Access Systems (MAS) installed. Furthermore, Securus will ... be installed by October, 2016. MAS distinguishes between ...
Breaking Biology News(10 mins):